1. Comoli P, Basso S, Huanga GC. Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita: report of a case. Int J Hematol. 2005;82:35-37.
2. Drachtman RA, Alter BP. Dyskeratosis congenita: Clinical and genetic heterogeneity. Report of a new case and review of the literature. Am J Pediatr Hematol Oncol. 1992;14:297-304.
3. Marrone A, Dokal I. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev Mol Med. 2004;6:1-23.
4. Alter BP, Baerlocher G, Savage S, et al. Diagnosis of dyskeratosis congenita by telomere length. Pediatr Blood Cancer. 2005;44:537.
5. Baerlocher GM, Mak J, Tien T, Lansdorp PM. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry. 2002;47:89-99.